NCT02243852View on ClinicalTrials.gov

Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)

WithdrawnOBSERVATIONAL

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

June 6, 2017

Conditions

Growth Hormone Deficiency

Interventions

DRUG

Growth Hormone Replacement Therapy

An observational study of patients who are commencing GH replacement as part of their routine NHS clinical care to assess changes in serum FGF21 concentration and determine how these relate to changes in body composition.

Trial Locations (2)

L69 3GE

MARIARC, Liverpool

L9 7AL

University Hospital Aintree, Liverpool